Kala Pharmaceuticals ( (KALA) ) has released its Q3 earnings. Here is a breakdown of the information Kala Pharmaceuticals presented to its ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, ...

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

Anterior cervical discectomy and fusion (ACDF) is the most commonly used decompressive procedure in the cervical spine and is used for the treatment of single or multiple level disc disease.

Here is a breakdown of the information Belite Bio, Inc. ADR presented to its investors. Belite Bio, Inc. ADR is a clinical-stage biopharmaceutical company focused on developing novel treatments for ...

The genetic mutation that causes Huntington's disease (HD)—a devastating brain disease that disrupts mobility and diminishes ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

New data suggest the frequency of damage and repair processes correlates with disease severity and disability in multiple ...

This, in turn, means that a low magnesium and high homocysteine level could cause oxidative stress and DNA damage, thereby increasing the risk of degenerative diseases, cancers, and accelerated aging.

New research supports brain cell transplantation as a treatment for some neurological disorders. A team from McGill ...

Tallulah Moon, 5, has been diagnosed with SPG56, a degenerative brain ... his son received the one-time treatment, which halted progression of the disease. Following Pirovolakis’ lead, Whitrod ...